Private Equity
Foundation Capital has named RJ Jain as entrepreneur-in-residence. Previously, Jain was the director of engineering at Sidecar Technologies.
2 min read · 29 April 2015
Flare Capital Partners has raised $200 million for its first healthcare tech-focused fund. The fund has already made investments in such companies as Iora Health, Predilytics and Valence Health. It also has invested in Rock Health's most recent seed fund. In addition to the fund, the firm has named Kristen Laguerre as partner and chief financial officer. Previously, Laguerre was a partner and CFO at Atlas Venture and vice president of finance at SoftBank Capital. Also, Flare has appointed Dr. Dan Gebremedhin as a senior associate.
3 min read · 29 April 2015
2nd Watch said Tuesday that it named Scott Parrish to the CFO position. Parrish was most recently CFO of Azaleos Corp. 2nd Watch said it also added Justin Jaschke to its board. Seattle-based 2nd Watch is a public cloud management company.
3 min read · 29 April 2015
Canadian alternative assets investor Kensington Capital Partners has opened an office in Calgary. The initiative is intended to help access new energy technology opportunities in Western Canada for Kensington Venture Fund, a venture fund of funds that raised an initial $160 million last November. Kensington's office in Calgary will be led by Senior Vice President Michelle Scarborough, previously a founder and managing partner of Canadian venture capital firm Fronterra Ventures. Scarborough is also the chair of the National Angel Capital Organization, and the founder of the Women's Angel Network in Canada.
5 min read · 28 April 2015
Lexington, Massachusetts-based Synta Pharmaceuticals Corp, a biopharmaceutical company focused on developing cancer medicines, has promoted Chen Schor from executive vice president and chief operating officer to president, CEO and director of the company. The change becomes effective May 7, 2015. Schor will be replacing Anne Whitaker who is leaving to pursue an opportunity at an unnamed pharmaceutical company. Schor is a former partner at at Yozma Venture Capital.
3 min read · 27 April 2015
Institutional Venture Partners closed a $1.4 billion fifteenth fund, its largest ever, saying the opportunities in tech investing deserve putting extra capital to work.
2 min read · 23 April 2015
Infinio said Wednesday that Bob Skelley was named VP of global channel and will manage all channel and partner relationships for Infinio globally. Skelley previously served as Dell’s executive director of North American channel sales. Infinio investors include Bessemer Venture Partners, Highland Capital Partners, Lightspeed Venture Partners and Osage University Partners.
3 min read · 23 April 2015
Intellia Therapeutics, a developer of therapeutic products for gene editing and repair, has named Dr. Sapna Srivastava as chief financial and strategy officer. She is a former senior analyst and biotechnology group team leader at Goldman Sachs. Intellia Therapeutics is backed by Atlas Venture and Novartis Institutes for Biomedical Research.
2 min read · 22 April 2015
French gene therapy company Lysogene has named Annette Clancy as chair of the board of directors. Currently, Clancy is the board chair of Genable Technologies Ltd and ObsEva Ltd. Lysogene's backers include Sofinnova Partners.
2 min read · 20 April 2015
Frazier Healthcare said Wednesday that Chris Karkenny has joined its growth buyout team as an operating partner. Karkenny previously served as Executive Vice President and Chief Financial Officer at Apria Healthcare.
3 min read · 16 April 2015
